title: Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization.
authors.forename: José R
authors.initials: JR
authors.lastname: Foruny
authors.forename: Rafael
authors.initials: R
authors.lastname: Bárcena
authors.forename: Ana
authors.initials: A
authors.lastname: Moreno
authors.forename: Javier
authors.initials: J
authors.lastname: Blázquez
authors.forename: Rebeca
authors.initials: R
authors.lastname: Manzano
authors.forename: Luis A
authors.initials: LA
authors.lastname: Gil-Grande
authors.forename: Alberto
authors.initials: A
authors.lastname: Moreno
authors.forename: Javier
authors.initials: J
authors.lastname: Nuño
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D006526:Hepatitis C / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D007074:Immunoglobulin G; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a